Brain macrophage senescence in glioma
Seminars in Cancer Biology · 2024
DOI: 10.1016/j.semcancer.2024.07.005 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2024. Verfasst von Lu Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China. Hauptthemen laut MEDLINE: Glioma, Cellular Senescence, Macrophages, Brain Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 175 Literaturangaben. Gefördert von: Natural Science Foundation of Liaoning Province.
Abstract (Originalsprache)
Gliomas are a diverse group of primary central nervous system neoplasms with no curative therapies available. Brain macrophages comprise microglia in the brain parenchyma, border-associated macrophages in the meningeal-choroid plexus-perivascular space and monocyte-derived macrophages infiltrating the brain. With the great improvement of our recognition of brain macrophages, diverse macrophage populations have been found in the context of glioma, which exhibit functional and phenotypic heterogeneity. We have long thought that brain macrophage senescence is detrimental, manifested by specialized forms of persistent cell cycle arrest and chronic low-grade inflammation. Persistent senescence of macrophages may result in immune dysfunction, potentially contributing to glioma initiation and development. Given the crucial roles played by brain macrophages in glioma, we unravel how brain macrophages undergo reprogramming and their contribution to glioma. We outline general molecular alterations and specific biomarkers in senescent brain macrophages, as well as functional changes (such as metabolism, autophagy, phagocytosis, antigen presentation, and infiltration and recruitment). In addition, recent advances in genetic regulation and mechanisms linked to senescent brain macrophages are discussed. In particular, this review emphasizes the contribution of senescent brain macrophages to glioma, which may drive translational efforts to utilize brain macrophages as a prognostic marker or/and treatment target in glioma. An in-depth comprehending of how brain macrophage senescence functionally influences the tumor microenvironment will be key to our development of innovative therapeutics for glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.
- Department of Neurosurgery, The People's Hospital of China Medical University, The People's Hospital of Liaoning Province, Shenyang, Liaoning 110016, China.
- Department of Rehabilitation, The Central Hospital of Shenyang Medical College, Shenyang, Liaoning 110024, China.
- Rehabilitation Medicine Department, The People's Hospital of China Medical University, The People's Hospital of Liaoning Province, Shenyang, Liaoning 110016, China. Electronic address: d1848@lnph.com.
- Department of Rehabilitation, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China. Electronic address: 20142251@cmu.edu.cn.
Förderung
- Natural Science Foundation of Liaoning Province
Zitieren
APA
Li, L., Zhang, T., Xiao, M., Lu, Y., & Gao, L. (2024). Brain macrophage senescence in glioma. Seminars in Cancer Biology. https://doi.org/10.1016/j.semcancer.2024.07.005
Vancouver
Li L, Zhang T, Xiao M, Lu Y, Gao L. Brain macrophage senescence in glioma. Seminars in Cancer Biology. 2024. doi:10.1016/j.semcancer.2024.07.005
BibTeX
@article{Li2024,
author = {Li, Lu and Zhang, Tianhe and Xiao, Meiling and Lu, Yu and Gao, Lin},
title = {Brain macrophage senescence in glioma},
journal = {Seminars in Cancer Biology},
year = {2024},
doi = {10.1016/j.semcancer.2024.07.005}
}
EUVIMED